]>
IRCT20251118068042N1 IRCT 2025-12-16 Shahroud University of Medical Sciences The effect of tele-palliative care on hope and fear of disease progression in Gastrointestinal cancer patients The effect of tele-palliative care on hope and fear of disease progression in Gastrointestinal cancer patients: A parallel randomized clinical trial 2026-02-20 anticipated 74 Recruiting https://irct.ir/trial/87775 interventional Randomization: Randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: In the present study, the researcher will select participants from the research environment by referring to the research environment and finding eligible individuals based on inclusion and exclusion criteria. Then, an individual outside the research team, considering the order of entry of individuals into the study, will assign the patient to one of the two groups, palliative care intervention or the control group, using an allocation sequence concealed in white envelopes. The method of concealing the sequence is the use of white envelopes, which will be prepared in 74 numbers, and each sequence will be placed inside a white envelope, and the envelopes will be numbered. N/A Gastrointestinal cancers. Intervention 1: Intervention group: Participants will receive palliative care intervention in the WhatsApp software environment. Each session will last 30 to 45 minutes, and one session per week will be held for participants for 6 weeks. In each session, the content of the sessions will be provided to the participants in the form of educational clips. Intervention 2: Control group: Participants will receive the same routine treatments and care they received before participating in the study, and at the end of the intervention for the experimental group and after the completion of data collection, the research intervention will also be shared with the control group. Undecided - It is not yet known if there will be a plan to make this available Justification or reason for indecision in sharing IPD is There is no further information
public Dr. Hossein Bagheri
Haft Tir Square, Shahroud University of Medical Sciences
Shahroud Iran (Islamic Republic of) 3614773943 +98 23 3239 5054 bagheri@shmu.ac.ir Shahroud University of Medical Sciences scientific Dr. Hossein Bagheri
Haft Tir Square, Shahroud University of Medical Sciences
Shahroud Iran (Islamic Republic of) 3614773943 +98 23 3239 5054 bagheri@shmu.ac.ir Shahroud University of Medical Sciences Iran (Islamic Republic of) Iran (Islamic Republic of) The patient's age should be between 20 and 60 years old. The patient has a confirmed diagnosis of gastrointestinal cancer at stage II or III. Must be able to read and write. The patient must have a smartphone equipped with WhatsApp software on their mobile phone. Has undergone at least one chemotherapy session. 20 years 60 years Both Having severe mental disorders (diagnosed and confirmed by a physician). Taking neuroleptic medications. Having a serious physical condition caused by cancer. Having uncorrectable vision and hearing impairments. Participation in any palliative care program during the course of the illness. C15-C26 Gastrointestinal cancers Treatment - Other Treatment - Other Intervention group: Participants will receive palliative care intervention in the WhatsApp software environment. Each session will last 30 to 45 minutes, and one session per week will be held for participants for 6 weeks. In each session, the content of the sessions will be provided to the participants in the form of educational clips. Control group: Participants will receive the same routine treatments and care they received before participating in the study, and at the end of the intervention for the experimental group and after the completion of data collection, the research intervention will also be shared with the control group. Hope in Gastrointestinal cancer Patients. Timepoint: Before the start of the intervention, immediately and one month after the end of the intervention. Method of measurement: Hirsch Hope Index (HHI) Questionnaire. Fear of disease progression in Gastrointestinal Cancer Patients. Timepoint: Before the start of the intervention, immediately and one month after the end of the intervention. Method of measurement: Fear of Disease Progression Questionnaire (FoP-Q-SF). Shahroud University of Medical Sciences Approved 2025-11-15 Ethics Committee of Shahroud University of Medical Sciences Haft Tir Square Shahroud Semnan Iran (Islamic Republic of)